on Thursday announced the appointment of Amit Kaptain as Chief Executive Officer (CEO) of the Company. According to the corporate, Amit shall be liable for constructing business technique and longstanding global partnerships with main pharmaceutical firms by growing products in area of interest therapeutic areas, and thereby becoming a reliable partner of selection from India.
“Prior to joining Ami Lifesciences, Amit labored as COO at Aurore Lifesciences. Prior to that Amit labored at where he was liable for gross sales & marketing in India, Far & South-East Asia. He is a B.Sc. in Chemistry and Master of Marketing Management, NMIMS from University of Mumbai,” the corporate stated on Thursday.
The firm acknowledged that the with over 20 years of experience in the API business, Amit is a seasoned professional in driving sales, advertising and operations across international markets and has labored with massive Indian MNCs such as Dr. Reddy’s, Ranbaxy, and Sun Pharma.
“India has emerged as a serious pharmaceutical hub and witnessed rising demand for APIs from around the globe. With our scientific and technological capabilities, research and manufacturing competencies, Ami Lifesciences is poised to maximise its influence on the global pharmaceutical trade. We are delighted to welcome Amit to the group. Amit has 20+ years of sturdy domain experience in the API sector and has undertaken numerous leadership roles at Dr. Reddy’s Laboratories, SunPharma and Ranbaxy. We are assured that Ami Lifesciences will emerge as one of India’s leading and dependable API supplier beneath Amit’s management,” Girish Chovatia, Chairman and Managing Director, Ami Lifesciences stated in a statement.
On his appointment, Amit Kaptain mentioned that he's very excited to be part of the Ami Lifesciences progress story, and to companion with Girish Chovatia and the Kedaara group.
“I am very excited to be a half of the Ami Lifesciences progress story, and companion with Girish Chovatia and the Kedaara group. I am personally very excited in regards to the prospects of the API business and can leverage Ami Lifesciences’ robust product portfolio, R&D capabilities, and manufacturing competencies to create a world-class leader which shall be a reliable partner of alternative in India. I am looking forward to working with the experienced group of Ami Lifesciences to attain the company’s vision, growth, and enlargement plans,” Amit Kaptain mentioned in an announcement.
ALSO READ | Practo appoints senior docs to strengthen its medical team